Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
Clinical trial NCT01308294 · TERMINATED
Trial details
- NCT number
- NCT01308294
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.